Susquehanna International Group
ANRO icon

Susquehanna International Group’s Alto Neuroscience ANRO Stock Holding History

Susquehanna International Group’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$353K Buy
+15,700
New +$291K ﹤0.01% 10508
2025
Q1 		– Sell
-41,500
Closed -$176K – 13610
2024
Q4 		$176K Buy
+41,500
New +$259K ﹤0.01% 10868

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group's ANRO Position: Q1 2026 in Review

Susquehanna International Group increased its Alto Neuroscience (ANRO) stake by 102% in Q1 2026, buying an estimated $2.23M and bringing the position to 238,498 shares worth $5.36M. The position accounts for ﹤0.01% of the portfolio, ranked #4108.

Susquehanna International Group first reported a position in ANRO in Q4 2024 and has held it in 6 quarters since. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Susquehanna International Group held 238,498 shares of Alto Neuroscience worth $5.36M as of Q1 2026.
  • Susquehanna International Group bought 120,342 Alto Neuroscience shares in Q1 2026, an estimated $2.23M.
  • Alto Neuroscience made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4108 holding.
  • Susquehanna International Group first reported a position in Alto Neuroscience in Q4 2024 and has held it in 6 quarters since.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.